A Trial on the Efficacy and Safety of Virgin Coconut Oil Compared to Mineral Oil in the Treatment of Uremic Xerosis
A Randomized Controlled Trial on the Efficacy and Safety of Virgin Coconut Oil Compared to Mineral Oil in the Treatment of Uremic Xerosis
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
Among adult patients with chronic kidney disease undergoing hemodialysis, what is the efficacy and safety of virgin coconut oil compared to mineral oil as a therapeutic moisturizer for uremic xerosis?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Apr 2011
Shorter than P25 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 26, 2011
CompletedFirst Posted
Study publicly available on registry
October 3, 2011
CompletedOctober 3, 2011
September 1, 2011
4 months
September 26, 2011
September 29, 2011
Conditions
Outcome Measures
Primary Outcomes (3)
Change in baseline overall dry skin score
4 weeks
Change in baseline corneometer readings
Measurement of skin hydration
4 weeks
Change in baseline sebumeter readings
Measurement of skin lipids
4 weeks
Secondary Outcomes (3)
Change in Quality of life scores
4 weeks
Patient-assessed efficacy
4 weeks
Adverse events
4 weeks
Study Arms (2)
Virgin Coconut Oil
EXPERIMENTALMineral Oil
ACTIVE COMPARATORInterventions
Virgin coconut oil applied to the test site twice daily for four weeks
Eligibility Criteria
You may qualify if:
- Adults undergoing maintenance hemodialysis who have mild to severe uremic xerosis
You may not qualify if:
- Patients with known hypersensitivity to the tests oils were excluded from the study as well as patients with open wounds, erosions, and ulcers on the test site and paraplegics and patients with altered sensation on the test sites.
- Patients with xerosis associated with other dermatologic conditions antedating renal failure were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacqueline Michelle G de las Alas, MD
University of the Philippines
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Officer III
Study Record Dates
First Submitted
September 26, 2011
First Posted
October 3, 2011
Study Start
April 1, 2011
Primary Completion
August 1, 2011
Study Completion
August 1, 2011
Last Updated
October 3, 2011
Record last verified: 2011-09